|
| related topics |
| {regulation, government, change} |
| {product, liability, claim} |
| {debt, indebtedness, cash} |
| {product, market, service} |
| {provision, law, control} |
| {stock, price, operating} |
| {investment, property, distribution} |
| {gas, price, oil} |
| {acquisition, growth, future} |
| {loss, insurance, financial} |
|
|
Failure to complete the Fresenius Medical Care transaction could negatively impact the market price of our common stock and our ability to operate our business.
Our profits are dependent on the services we provide to a small portion of our patients who are covered by private insurance.
If Congress or CMS changes the Medicare or Medicaid programs for dialysis, then our net revenue and earnings could decrease.
If states lower Medicaid reimbursement, then we would be less profitable.
If reimbursement for EPO decreases, then we could be less profitable.
If Amgen raises the price for EPO or if EPO becomes in short supply, then we could be less profitable.
Changes in our clinical practices or reimbursement rules for EPO and other drugs could substantially reduce our revenue and earnings.
If our business is alleged or found to violate heath care or other applicable laws, our net revenue and earnings could decrease.
Government investigations could adversely affect Renal Care Group.
If our joint ventures violate the law, our business could be damaged.
Changes in the health care delivery, financing or reimbursement systems could adversely affect our business.
If local physicians stop sending patients to our centers or were prohibited from doing so for regulatory reasons, then our revenue and earnings would decline.
The dialysis business is highly competitive. If we do not compete effectively in our markets, then we could lose market share and our rate of growth could slow.
If we are unable to make acquisitions in the future, then our rate of growth will slow.
If acquired businesses have unknown liabilities, then we could be exposed to liabilities that could harm our business and profitability.
We may not have sufficient cash flow from our business to pay our substantial debt.
The large amount and terms of our outstanding debt may prevent us from taking actions we would otherwise consider in our best interest.
If our costs of insurance and claims increase, then our earnings could decrease.
If our board of directors does not approve an acquisition or change in control, then our shareholders may not realize the full value of their stock
Our stock price is volatile and as a result, the value of your investment may go down for reasons unrelated to the performance of our business.
Full 10-K form ▸
|
|
| related documents |
| 927066--2/29/2008--DAVITA_INC |
| 927066--2/25/2010--DAVITA_INC |
| 882235--2/25/2009--LINCARE_HOLDINGS_INC |
| 882235--2/25/2010--LINCARE_HOLDINGS_INC |
| 882235--2/27/2008--LINCARE_HOLDINGS_INC |
| 882289--3/16/2006--APRIA_HEALTHCARE_GROUP_INC |
| 831967--2/23/2007--KINETIC_CONCEPTS_INC_/TX/ |
| 776325--3/12/2008--RES_CARE_INC_/KY/ |
| 1260996--4/15/2009--AMERICAN_DEFENSE_SYSTEMS_INC |
| 1139463--12/14/2010--MEDCATH_CORP |
| 893949--8/7/2007--PEDIATRIX_MEDICAL_GROUP_INC |
| 831641--12/28/2006--TETRA_TECH_INC |
| 893949--2/28/2008--PEDIATRIX_MEDICAL_GROUP_INC |
| 882235--3/2/2007--LINCARE_HOLDINGS_INC |
| 927066--2/28/2007--DAVITA_INC |
| 1064863--3/1/2006--AMERIGROUP_CORP |
| 813562--9/13/2007--NATIONAL_MEDICAL_HEALTH_CARD_SYSTEMS_INC |
| 1047335--3/2/2010--NATIONAL_HEALTHCARE_CORP |
| 1179929--3/14/2007--MOLINA_HEALTHCARE_INC |
| 1129623--3/14/2008--ODYSSEY_HEALTHCARE_INC |
| 930420--3/3/2006--KFORCE__INC |
| 1129623--3/10/2006--ODYSSEY_HEALTHCARE_INC |
| 1007330--3/12/2008--PRG_SCHULTZ_INTERNATIONAL_INC |
| 1361579--3/18/2008--Virtual_Radiologic_CORP |
| 1047335--3/17/2008--NATIONAL_HEALTHCARE_CORP |
| 1129623--3/10/2010--ODYSSEY_HEALTHCARE_INC |
| 927066--2/27/2009--DAVITA_INC |
| 44800--3/8/2006--ANALEX_CORP |
| 1139463--12/14/2007--MEDCATH_CORP |
| 892537--3/10/2006--MANTECH_INTERNATIONAL_CORP |
|